[go: up one dir, main page]

(Q34296575)

English

EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy (English)
Ingo K Mellinghoff

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit